Quadcap Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.16M Buy
2,364
+16
+0.7% +$8.68K 0.13% 143
2025
Q4
$1.36M Buy
2,348
+45
+2% +$25.4K 0.16% 123
2025
Q3
$1.12M Buy
2,303
+396
+21% +$184K 0.13% 143
2025
Q2
$773K Sell
1,907
-126
-6% -$52.7K 0.1% 181
2025
Q1
$1.01M Sell
2,033
-142
-7% -$76.9K 0.15% 138
2024
Q4
$1.13M Sell
2,175
-154
-7% -$84.7K 0.17% 120
2024
Q3
$1.44M Buy
2,329
+9
+0.4% +$5.33K 0.23% 96
2024
Q2
$1.28M Sell
2,320
-18
-0.8% -$10.3K 0.23% 94
2024
Q1
$1.36M Sell
2,338
-96
-4% -$53.9K 0.31% 74
2023
Q4
$1.29M Buy
+2,434
New +$1.18M 0.33% 74

Other funds holding TMO

Quadcap Wealth Management's TMO Position: Q1 2026 in Review

Quadcap Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 0.68% in Q1 2026, buying an estimated $8.68K and bringing the position to 2,364 shares worth $1.16M. The position accounts for 0.13% of the portfolio, ranked #143.

Quadcap Wealth Management first reported a position in TMO in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.44M in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Quadcap Wealth Management held 2,364 shares of Thermo Fisher Scientific worth $1.16M as of Q1 2026.
  • Quadcap Wealth Management bought 16 Thermo Fisher Scientific shares in Q1 2026, an estimated $8.68K.
  • Thermo Fisher Scientific made up 0.13% of Quadcap Wealth Management's portfolio in Q1 2026, its #143 holding.
  • Quadcap Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 10 quarters since.
  • Quadcap Wealth Management's Thermo Fisher Scientific position peaked at $1.44M in Q3 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Quadcap Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.